Dementia Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

what are normal, age-associated cognitive changes?

A
  • difficulty retrieving words and names
  • slower processing speed
  • difficulty sustaining attention when faced with competing environmental stimuli
  • learning something takes bigger effort
  • no functional impairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the definition of mild cognitive impairment (MCI)?

A
  • memory complaint corroborated by an informant
  • objective memory impairment for age and education
  • preserved general cognition
  • normal activities of daily living
  • not demented
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is amnestic MCI?

A

memory loss not meeting criteria for dementia

  • progresses to AD at risk of 10-15% per year VS 1-3% incidence in general population
  • may be earliest phase of AD
  • it’s a clinical diagnosis, as there’s no test for MCI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the DSM-IV diagnostic criteria for dementia (DSM-5 is neurocognitive disorder, mild/major)

A
  1. memory decline/impairment and at least one of the following:
    - aphasia
    - apraxia
    - impaired executive function
    - agnosia
    - DSM5: decline in memory, complex attention, executive function, learning/memory, language, perceptual/motor, social cognition
  2. cognitive deficits must impact social and occupational function
    - major: patient incapable of independent living
  3. diagnosis must be made in presence of clear sensorium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

early onset AD

A

occurs between 30-60 yo

  • rare, and familial in most cases
  • single gene mutation:
  • -1: abnormal presenilin 2
  • -14: abnormal presenelin 1
  • -21: abnormal amyloid precursor protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

late onset AD

A

most common form

  • develops after age 60
  • combination of factors is responsible (vascular, diabetic, etc)
  • Xm 19: apolipoprotein E4 is implicated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does AD look like grossly?

A

cerebral atrophy, especially affecting temporal, parietal, and frontal areas, with ventricular enlargement

  • flat gyri, wide sulci
  • hippocampus shrinks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what does AD look like microscopically?

A
  1. amyloid plaques (extracellular deposits of beta-amyloid peptide) associated with dystrophic neurites (neuritic plaques)
  2. A-beta deposits in cortical and leptomeningeal arteries and arterioles (amyloid angiopathy)
  3. neurofibrillary tangles and neuropil threads (filamentous intracellular inclusions of tau protein)
  4. granulovacuolar degeneration (GVD)
  5. Hirano bodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the steps to forming the APP molecule?

A

pathologic cleavage by beta and gamma secretases

  • creates 40 or 42 (seed, worse)
  • creates neural network dysfunction, tau abnormalities, neurodegeneration, nt deficits, and memory impairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the difference between neuritic plaques and diffuse plaques?

A

neuritic: larger, with dark brown center (represents 42 APP seed)
diffuse: smaller, don’t have brown center (40 APP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what does cerebral amyloid angiopathy look like?

A

smooth muscle of vessels has been replaced by amyloid

-may cause hemorrhage and more vascular dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the major component of neurofibrillary tangles?

A
hyperphosphorylated tau (microtubule-associated protein)
-dissociates from microtubules and assembles to form paired helical filaments, which are bundled together to form NFTs and neuropil threads (periphery of plaques)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe what granulovascular degeneration and Hirano bodies are

A

nonspecific features of AD observed in hippocampi

-also in regular brains, so not important diagnostically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the difference between FTLD-Tau and FTLD-TDP?

A
  1. FTLD-Tau is Pick’s disease, and more common
  2. FTLD-TDP has no tau protein

both have profound anterior frontal and superior temporal knife-edge atrophy (parietal and occipital are spared)
-eccentric asymmetrical nuclei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are vulnerable neurons in AD? the cytopathology?

A

hippocampus, entorhinal cortex, neocortex, basal forebrain cholinergic system
-NFT, neurites, A-beta deposition, and other cellular abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

which are more diagnostic and which come sooner between A-beta plaques and tau proteins?

A

A-beta come sooner, but tau proteins are more diagnostic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are AD risk factors?

A
  • increasing age
  • female
  • FH of dementia, apolipoprotein E4 allele
  • fewer years of education
  • lower income and occupational status
  • depression or other emotional illness
  • head injury, post-operative delirium, alcohol abuse
  • low folate, B12
  • high plasma homocysteine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the 3 key features of AD?

A
  1. impaired cognition
  2. impaired function
  3. behavioral disturbances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are early cognitive symptoms of AD?

A
  • trouble keeping appointments
  • difficulty finding words
  • misplacing objects (unable to retrace steps)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are early functional symptoms of AD?

A
  • difficulty driving
  • difficulty selecting appropriate clothes, or wearing same thing every day
  • missing appointments
  • problems at work
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are early behavioral symptoms of AD?

A
  • subtle changes in personality
  • social withdrawal
  • depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

how does primary depression differ from dementia?

A
  • less motivation during cognitive testing (dementia patients try very hard)
  • express cognitive complaints that exceed measured deficits
  • maintain language and motor skills
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

why is it important to diagnose AD early?

A
  • rule out reversible causes
  • initiate appropriate therapy
  • enrollment for clinical trials
  • advance directives and planning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

brain imaging in regards to AD?

A

not routinely indicated, but consider if:

  • focal findings on exam
  • rapid onset/decline
  • falls, head trauma by history

nonspecific findings are common in AD, vascular dementia:
-lacunar infarcts, small vessel changes, white matter disease

25
Q

how is Pick’s disease different from Alzheimer’s?

A

frontotemporal dementia

  • insidious onset, gradual progression
  • early decline in social interpersonal conduct (losing their “filter”)
  • early impairment in regulation of personal conduct with loss of insight
  • early emotional blunting
  • behavioral abnormalities
  • memory loss occurs later
26
Q

what are Rx for Pick’s disease?

A
  • no role for cholinesterase inhibitors
  • careful use of atypical antipsychotics (quetiapine, risperdol)
  • divalproex (anti-seizure) for behavior control
  • SSRIs for irritability, depression, impulsive behavior
27
Q

what are Rx for Alzheimer’s disease?

A

nothing is disease-modifying; can only manage symptoms

  • cholinergic therapy (cholinesterase inhibitors) are only symptom modifying
  • NMDA receptor antagonists
  • investigational agents
  • treatment of neuropsychiatric symtpoms
28
Q

why was the AD vaccine pulled?

A

it caused other neurological problems

29
Q

why do anticholinesterases “work”?

A

degeneration of basal nucleus of Meynert causes wide-spread ACh deficiency

  • contributes to memory deficits that characterize the disorder
  • anticholinesterases block degradation of ACh, hopefully leaving enough in synapses to slow progression
30
Q

what is the mechanism, dose, metabolism, and ASE of tacrine?

A

(now obsolete) AChE and BuChE inhibitors

  • 4x a day
  • metabolized by cyt P450
  • ASE: nausea, vomiting, diarrhea, cramps, serum transaminase elevation
31
Q

what is the mechanism, dose, metabolism, and ASE of donepezil?

A

AChE inhibitor

  • 1x a day (start at low dose)
  • metabolized by cyt P450
  • ASE: N/V, sleep disturbance, syncope, hypotension
32
Q

what is the mechanism, dose, metabolism, and ASE of rivastigmine?

A

AChE and BuChE inhibitor

  • 2x a day, and can use transdermal patch
  • metabolized by hydrolysis via cholinesterases
  • ASE: N/V, sleep disturbance
33
Q

what is the mechanism, dose, metabolism, and ASE of galantamine?

A

AChE inhibitor, allosteric modulator of nicotinic receptors

  • 1-2x a day (can use ER version)
  • metabolized by cyt P450
  • ASE: N/V, sleep disturbance
34
Q

what is the mechanism, dose, metabolism, and ASE of memantine?

A

partial antagonist of NMDA (receptor blocker as excitotoxicity by glutamate may cause neuronal damage)

  • 2x a day
  • most is excreted unchanged in urine
  • ASE: dizziness, confusion, headache, constipation
35
Q

what do you use to treat neuropsychiatric disturbances in AD patients?

A
  • antipsychotics: risperidone, haloperidol
  • antidepressants: sertraline, venlafaxine
  • anxiolytics: buspirone, lorazepam
36
Q

explain what vascular dementia is

A

multi-infarct dementia (depends on region and volume of tissue affected)
-may be due to and/or cerebral ammyloid angiopathy or HTN-related small vessel disease

37
Q

explain how hypertensive small vessel disease can lead to progressive cognitive impairment

A

arteriosclerosis of small vessel arteries and arterioles supplying deep gray and white matter

  • lacunar infarcts
  • subcortical leukoencephalopathy
  • subcortical dementia
  • -cognitive slowing
  • -impaired problem solving
  • -visuospatial abnormalities
  • -disturbances in mood and affect
  • can result in diffuse, confluent demyelination and axon loss affecting deep white matter, especially periventricular
38
Q

what are the main targets for vascular dementia?

A

small vessels (lenticulostriate branches off MCA), which supply the basal ganglia and internal capsule

39
Q

vascular dementia clinically?

A

most common dementia after Alzheimer’s

  • “step-wise” progression that can be abrupt after CVA
  • -after each accident, lose more abilities, then level off
  • usually seen with cardiovascular risk factors
  • “mixed” dementia with AD or Lewy body is not unusual
  • emotional liability
40
Q

what is treatment for vascular dementia?

A
focus on controlling CV risk factors
-maximize blood pressure control
-statins
-stop smoking
-control blood sugar
-diet (no simple carbs)
-exercise
Rx: cholinesterase inhibitors
41
Q

what are Lewy bodies?

A

intracellular, fibrillar deposits of alpha-synuclein (presynaptic terminal protein)
-primarily in sporadic disorders, and most commonly Parkinson’s disease or Lewy body dementia

42
Q

describe Parkinson’s disease clinically

A

most common cause of parkinsonism (resting tremor, postural instability, impaired voluntary movement)

  • most cases are sporadic, affecting 1-2% of people >65 yo
  • bradykinesia, shuffling gait, and parkinsonism due to dopaminergic deficit
  • responsive to L-dopa therapy
43
Q

where is the marked pathology in Parkinson’s disease?

A

pars compacta, locus ceruleus, substantia nigra

44
Q

what does PD look like grossly?

A

pallor of substantia nigra

45
Q

what does PD look like microscopically?

A

degeneration and loss of pigmented, dopaminergic neurons of SN pars compacta and other pigmented neurons of brainstem, like locus ceruleus

  • contain 1+ eosinophilic Lewy body inclusions
  • striatum, thalamus, and some cortical regions are functionally affected by loss of dopaminergic input
46
Q

what happens to pigment after neuron dies?

A

“neuromelanin” is phagocytosed by macrophages

47
Q

explain the pathogenesis of PD

A
  1. mutations in alpha-synuclein gene that are AD
    - presynaptic protein that regulate synaptic vesicle trafficking
    - if misfolded, may act as a prion and spread between cells
  2. LB are made of fibrillar aggregates of a-synuclein (also make Lewy neurites)
    - some of these are toxic
  3. impaired protein degradation, inhibition of oxidative phosphorylation, impaired axonal transport, oxidative stress
  4. pesticide exposure may be risk factor
48
Q

explain what dementia with Lewy bodies is clinically

A

sporadic, primarily late onset, with less-affected memory (may be short term and gradual)

  • frontal and subcortical features (deficits in attention and alertness are prominent)
  • pronounced fluctuations and variations in symptoms (may seem like delirium)
  • neuropsychiatric symptoms: vivid visual hallucinations, delusions, REM sleep disorder, autonomic dysfunction
  • motor symptoms of PD are variably present (frequent falls)
49
Q

what are gross features of dementia with Lewy bodies (DLB)?

A

nigral pallor

  • cortical atrophy is less severe than in AD
  • atrophy of limbic areas is often significant
50
Q

what are microscopic features of dementia with Lewy bodies (DLB)?

A
  1. “cortical”-type LBs in frontal, temporal, and insular cortex, and in limbic areas (amygdala, cingulate gyrus)
  2. nigral LBs
  3. LNs, especially in hippocampus and striatum
  4. DLB patients usually have plaques and tangles, and a dual diagnosis of DLB and AD applies in most cases
51
Q

treatments for lewy body dementia?

A
  • cholinesterase inhibitors may provide symptomatic support
  • trial of carbidopa/levodopa for esvere movement symptoms
  • avoid antipsychotic drugs due to increased sensitivity
  • REM sleep disorder can be treated with clonazepam
52
Q

how can you tell the difference between Lewy body dementia and Parkinson’s?

A

LBD: onset of dementia within 12 months of parkinsonism (dementia precedes movement disorder)

PD: onset of dementia more than 12 months after diagnosis of PD (movement problems precede dementia)

53
Q

explain what the MMSE is and scoring

A

mini mental status examination

  • standard 30 point rating scale that is screening, not diagnosing, and not specific for dementia type
  • scoring can be impacted by age, education, and ethnicity
  • -normal: 27-30
  • -mild: 20-30
  • -moderate: 10-20
  • -severe: <10
54
Q

explain what the MoCA is and scoring

A

Montreal cognitive assessment

  • standardized 30 point rating scale that is screening, not diagnosing, and not specific for dementia type
  • scoring can be impacted by age, education, and ethnicity
  • -normal: >26
  • -mild: 18-26
  • -moderate: 10-17
  • -severe: <10
55
Q

what are the basic activities of daily living?

A

BADLs:

  • Dressing
  • Eating
  • Ambulating
  • Toileting
  • Hygiene

need nursing home

56
Q

what are the instrumental activities of daily living?

A

IADLs:

  • Shopping
  • Housekeeping
  • Accounting
  • Food preparation
  • Transportation

need helper or assisted living

57
Q

what are adult homes?

A

provide a room and meals

  • can add on assistance with daily activities
  • no complex medical problems
  • not always licensed or monitored by local authorities
  • cash only
58
Q

what are assisted living facilities?

A
  • assistance with IADLs
  • can add on some BADLs for extra fee
  • no medical or nursing care on-site
  • cash only, and NOT covered by Medicaid or Medicare
59
Q

what are skilled nursing facilities?

A

most widely recognized option

  • daily skilled nursing care and onsite medical care
  • dependent in all BADLs
  • most patients have advanced dementia
  • cash until money is depleted
  • -most residents on Medicaid